Register Today for National Harm Reduction TA Center Information Session
The National Harm Reduction Technical Assistance Center (NHRTAC) is hosting an information sessionExit Disclaimer on Monday, June 13, from 3:00-4:00 PM (ET) about its resources and free technical assistance. The TA Center offers access to resources and highly-qualified experts help to anyone in the country providing harm reduction services – or even those planning to provide services – including organizations such as syringe services programs, health departments, and substance use disorder treatment, prevention, and recovery programs.
Harm reduction is a proactive and evidence-based approach to preventing overdose, the spread of infectious disease, and reducing other harms associated with substance use. The National Harm Reduction Technical Assistance Center is supported by CDC and SAMHSA, with the goal of integrating harm reduction strategies and principles across all types of programs that work to improve the health of people who use drugs.
During the webinar, participants will learn more about:
- NHRTAC’s goals, including how to support the integration of harm reduction strategies and principles across diverse community settings
- NHRTAC’s TA providers and the expertise that they can offer
- Successful collaborations between previous TA recipients and TA providers
- How to submit a TA request
Harm reduction is an important strategy for addressing the syndemic of substance use, HIV, and viral hepatitis. Syringe services program (SSPs), in particular, are safe, effective, and cost-saving approaches to preventing and reducing the infectious disease consequences of drug use, especially HIV and hepatitis C. The National HIV/AIDS Strategy (NHAS) calls for expanding and improving implementation of SSPs and other harm reduction services. The NHAS also recognizes community-based substance use and harm reduction programs as important partners in achieving the Strategy’s goals. Similarly, the Viral Hepatitis National Strategic Plan embraces harm reduction as a strategy to reduce hepatitis B and C infections. Further, expanding access to harm reduction services is a key strategy in the White House’s National Drug Control Strategy.